Esther Hong
Stock Analyst at Loop Capital
(n/a)
# 5,087
Out of 5,090 analysts
16
Total ratings
8.33%
Success rate
-41.72%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Esther Hong
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ATAI Atai Beckley | Initiates: Buy | $18 | $4.32 | +316.67% | 2 | Nov 1, 2022 | |
| ACAD ACADIA Pharmaceuticals | Initiates: Hold | $17 | $27.44 | -38.05% | 2 | Nov 1, 2022 | |
| CMPS COMPASS Pathways | Initiates: Buy | $34 | $5.82 | +484.19% | 1 | Nov 1, 2022 | |
| AXSM Axsome Therapeutics | Initiates: Buy | $95 | $149.22 | -36.34% | 2 | Nov 1, 2022 | |
| SPRO Spero Therapeutics | Downgrades: Hold | $2 | $2.26 | -11.50% | 2 | May 20, 2022 | |
| ATHA Athira Pharma | Initiates: Buy | $330 | $3.90 | +8,361.54% | 1 | Apr 21, 2022 | |
| APRE Aprea Therapeutics | Downgrades: Hold | n/a | $1.06 | - | 2 | Aug 16, 2021 | |
| ALDX Aldeyra Therapeutics | Initiates: Buy | $32 | $4.70 | +580.85% | 4 | Dec 16, 2020 |
Atai Beckley
Nov 1, 2022
Initiates: Buy
Price Target: $18
Current: $4.32
Upside: +316.67%
ACADIA Pharmaceuticals
Nov 1, 2022
Initiates: Hold
Price Target: $17
Current: $27.44
Upside: -38.05%
COMPASS Pathways
Nov 1, 2022
Initiates: Buy
Price Target: $34
Current: $5.82
Upside: +484.19%
Axsome Therapeutics
Nov 1, 2022
Initiates: Buy
Price Target: $95
Current: $149.22
Upside: -36.34%
Spero Therapeutics
May 20, 2022
Downgrades: Hold
Price Target: $2
Current: $2.26
Upside: -11.50%
Athira Pharma
Apr 21, 2022
Initiates: Buy
Price Target: $330
Current: $3.90
Upside: +8,361.54%
Aprea Therapeutics
Aug 16, 2021
Downgrades: Hold
Price Target: n/a
Current: $1.06
Upside: -
Aldeyra Therapeutics
Dec 16, 2020
Initiates: Buy
Price Target: $32
Current: $4.70
Upside: +580.85%